Jump to content
Sign in to follow this  
Brian

In the Future Cancer Will Be Treated by Cutting It out of Your DNA

Recommended Posts

In the not so distant future, we will be tackling many diseases and cancers using the newest revolution in biotechnology that involves targeting very specific parts of DNA and then snipping it.

 

One such technique that has taken the biotechnology world by storm is CRISPR which involves the use of a cas9 endonuclease and guide RNA. This complex is recruited to a target sequence and cas9 cuts the desired region that results in a double strand break. With this double stranded DNA break, it can be ligated back together with a method called Non-Homologous End-Joining (NHEJ) to introduce random mutations via insertions/deletions to knock out a specific gene.

 

Another method of repair called Homology Directed Repair (HDR) involves using a repair template that has homology to the flanking region of the double stranded break which results in controlled gene editing allowing researchers to use it for gene knock-out, knock-in, tagging etc. 

 

 

crispr.thumb.jpg.e173be31f7dbdcdd43185f3

 

 

 

There are other competing methods such as TALENs (Transcription Activator-Like Effector Nucleases) which a French biotechnology company called Cellectis is using to experiment for possible cancer treatment. As mentioned above, CRISPR uses guide RNA to direct DNA breaks where as TALENs employs the use of 18 repeats of 34 amino acids that vary at amino acids 12 and 13 which is the "Repeat Variable Diresidue" or RVD; RVD mediates the DNA binding specificity. 

 

DNA-binding-code-for-TALENs.thumb.jpg.ad

(image credit: genecopeia)

 

A pair of TALEN are targeted to opposite sides of a desired break site. Each TALEN is a chimeric protein with Fok I nuclease domain that results in a specific double stranded break. 

 

talen.thumb.jpg.1b2637800f4401913da3dca9

(image credit: genecopoeia)

 

The use of this technology is detailed in article by Business Insider where an infant in the UK named Layla was born with leukemia that had failed to be treated using common cancer treatment modalities such as chemotherapy and bone marrow transplant. Doctors there knew about Cellectis's work with TALENs and reached out as a last ditch effort to save her. 

 

Cellectis accepted their request and began her therapy by targeting her T-cells using TALENs to stimulate her immune system to attack the cancer and the result was complete remission.

 

While many people will be weary of the possible abuse of such technologies, they should set those fears aside because it is this type of technology that will one day lead to the precise targeting and elimination of many diseases including cancer. 


View full article

  • Thumbs Up 1

Share this post


Link to post
Share on other sites

Well, to see CRISPR Cas9 in this website is ... surprising? Kudos to the article though, I think people (even non-biologist)  should aware of these technologies as they are revolutionising biotechnology and healthcare.

Edited by cherile
  • Thumbs Up 1

Share this post


Link to post
Share on other sites

I truly appreciate this extra technical info, not necessarily PC/Computer related, as I lost my father to cancer a few years back. 

I'm completely in support of technology's role in cancer detection, and ultimately reduction in cancer's fatality rate.

 

Thanks a bunch.

  • Thumbs Up 1

Share this post


Link to post
Share on other sites

awesome explanation, this would be the greatest revolution to biotechnology. I just hope it would happen soon before I lose more family from cancer. My dad died of cancer 10 years ago and my aunts 3 and 2 years ago.

  • Thumbs Up 1

Share this post


Link to post
Share on other sites

I believe a more promising method exists with the utilization of aptamers (artificial antibodies) to target cell-specific sequences. Either way, it's an amazing time to be alive and I had the privilege of using crispr in the lab during my Cell and Molecular Biology Major. Watch this space, Cancer may soon be something we tell our loved ones about as if it were the common cold.

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

  • Similar Content

    • By Brian
      In the not so distant future, we will be tackling many diseases and cancers using the newest revolution in biotechnology that involves targeting very specific parts of DNA and then snipping it.
       
      One such technique that has taken the biotechnology world by storm is CRISPR which involves the use of a cas9 endonuclease and guide RNA. This complex is recruited to a target sequence and cas9 cuts the desired region that results in a double strand break. With this double stranded DNA break, it can be ligated back together with a method called Non-Homologous End-Joining (NHEJ) to introduce random mutations via insertions/deletions to knock out a specific gene.
       
      Another method of repair called Homology Directed Repair (HDR) involves using a repair template that has homology to the flanking region of the double stranded break which results in controlled gene editing allowing researchers to use it for gene knock-out, knock-in, tagging etc. 
       
       

       
       
       
      There are other competing methods such as TALENs (Transcription Activator-Like Effector Nucleases) which a French biotechnology company called Cellectis is using to experiment for possible cancer treatment. As mentioned above, CRISPR uses guide RNA to direct DNA breaks where as TALENs employs the use of 18 repeats of 34 amino acids that vary at amino acids 12 and 13 which is the "Repeat Variable Diresidue" or RVD; RVD mediates the DNA binding specificity. 
       

      (image credit: genecopeia)
       
      A pair of TALEN are targeted to opposite sides of a desired break site. Each TALEN is a chimeric protein with Fok I nuclease domain that results in a specific double stranded break. 
       

      (image credit: genecopoeia)
       
      The use of this technology is detailed in article by Business Insider where an infant in the UK named Layla was born with leukemia that had failed to be treated using common cancer treatment modalities such as chemotherapy and bone marrow transplant. Doctors there knew about Cellectis's work with TALENs and reached out as a last ditch effort to save her. 
       
      Cellectis accepted their request and began her therapy by targeting her T-cells using TALENs to stimulate her immune system to attack the cancer and the result was complete remission.
       
      While many people will be weary of the possible abuse of such technologies, they should set those fears aside because it is this type of technology that will one day lead to the precise targeting and elimination of many diseases including cancer. 
×

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.